Provident Financial Services Inc.

6 days ago · businesswire.com

TORONTO--(BUSINESS WIRE)---- $RPX.V #Canada--RPX Gold Inc. (“RPX Gold” or the “Company”) (TSXV: RPX) (OTCQB: RDEXF) is pleased to announce gold (“Au”) assay results from 25 drill holes totalling 4,336 metres (“m”) from its 2026 ongoing drilling program at the Wawa Gold Project in Ontario. The Company has now completed approximately two-thirds of the drilling meterage planned to support the prefeasibility study (“PFS”) and approximately half of its planned 20,000 m 2026 drill program. The results will be included.

8 days ago · gurufocus.com

Positive results from the DESTINY-Lung04 Phase III trial showed AstraZeneca and Daiichi Sankyo's ENHERTUÂ (fam-trastuzumab deruxtecan-nxki) demonstrated a stat

14 days ago · prnewswire.com

First OX40 agonist to demonstrate clinical benefit in a randomized study INBRX-106 plus pembrolizumab delivers a 48.3% cORR and   72.4% of patients remain progression free at 6 months, compared with 26.5% and   42.8%   for pembrolizumab alone Results are most pronounced in HPV+ patients, with   cORR (80.0% vs 33.3%), CR rate (30.0% vs 0%), and PFS6 improvement (90.0% vs 33.0%) vs pembrolizumab alone Inhibrx will expand the Phase 2 study by approximately 50 HPV+ patients   and may serve as   a potential pathway to accelerated   approval Positive results support large expansion opportunities   into highly immunogenic tumors and combination with cancer vaccines SAN DIEGO, Sept. 8, 2026 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company"), a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates, today announced the primary endpoint results from the randomized and controlled Phase 2 portion of the HexAgon study, which is evaluating the safety and efficacy of INBRX-106, a hexavalent OX40 agonist, in combination with pembrolizumab (the combination arm) versus pembrolizumab monotherapy (the control arm) in first-line patients with treatment-naïve, PD-L1 positive (CPS ≥ 20) metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC).

20 days ago · globenewswire.com

TORONTO, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX: WM, OTCQB: WLBMF) (“Wallbridge” or the “Company”) is pleased to announce final assay results from seven holes completed during the 2026 metallurgical drilling program at the Fenelon Gold Project. These results provide further confidence in the geological and grade continuity of the deposit while delivering the high quality of sample material needed to better characterize gold recovery characteristics and metallurgical performance across the Fenelon deposit. The drilling targeted areas considered for underground mining in the March 2025 Preliminary Economic Assessment (“PEA”) and provided representative samples for metallurgical characterization and variability testing in support of the Pre-feasibility Study (“PFS”) currently underway.

21 days ago · zacks.com

Provident Financial (PFS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

1 month ago · globenewswire.com

ISELIN, N.J., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”), the holding company for Provident Bank (the “Bank”), today announced the pricing of its offering of $175 million of its 6.50% Fixed-to-Floating Rate Subordinated Notes due 2036 (the “Notes”) in a registered public offering (the “Offering”). The Notes will initially bear interest at 6.50% per annum from and including August 24, 2026 to, but excluding, September 1, 2031, with interest payable semiannually in arrears commencing on March 1, 2027. Commencing September 1, 2031, the interest rate on the Notes will reset quarterly to a floating rate per annum equal to a benchmark rate that is expected to be Three-Month Term SOFR (which is defined in the Notes) plus 239 basis points, with interest payable quarterly in arrears.

1 month ago · zacks.com

WSFS, PFS and SMBC within the Zacks Savings and Loan Industry will gain from improving loan demand. Digital upgrades will also improve operating efficiency.

2 months ago · zacks.com

Does Provident Financial (PFS) have what it takes to be a top stock pick for momentum investors? Let's find out.

2 months ago · globenewswire.com

Experienced finance leader assumes expanded role overseeing accounting strategy and financial reporting Experienced finance leader assumes expanded role overseeing accounting strategy and financial reporting

2 months ago · globenewswire.com

ISELIN, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) (the "Company") announced today that Michael E. Regan has been appointed to the boards of directors of the Company and its wholly owned subsidiary, Provident Bank, effective July 30, 2026.